Anavex Life Sciences Corp (AVXL)
8.935
+0.46
(+5.43%)
USD |
NASDAQ |
Nov 21, 11:51
Anavex Life Sciences Price: 8.935 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 8.28 | 8.48 | 8.05 | 8.475 | 923531.0 |
| Nov 19, 2024 | 7.57 | 8.32 | 7.31 | 8.24 | 1.475M |
| Nov 18, 2024 | 7.59 | 7.60 | 7.18 | 7.45 | 1.449M |
| Nov 15, 2024 | 8.00 | 8.061 | 7.42 | 7.445 | 2.011M |
| Nov 14, 2024 | 8.90 | 9.24 | 8.00 | 8.03 | 1.702M |
| Nov 13, 2024 | 9.15 | 9.39 | 8.88 | 8.89 | 971513.0 |
| Nov 12, 2024 | 8.98 | 9.598 | 8.88 | 9.02 | 1.314M |
| Nov 11, 2024 | 9.70 | 10.45 | 8.72 | 9.15 | 2.869M |
| Nov 08, 2024 | 7.62 | 9.255 | 7.59 | 9.24 | 2.946M |
| Nov 07, 2024 | 7.80 | 8.08 | 7.55 | 7.635 | 1.253M |
| Nov 06, 2024 | 7.85 | 8.10 | 7.65 | 7.79 | 1.451M |
| Nov 05, 2024 | 7.22 | 8.10 | 7.19 | 7.70 | 2.124M |
| Nov 04, 2024 | 6.82 | 7.44 | 6.62 | 7.30 | 2.158M |
| Nov 01, 2024 | 6.81 | 7.07 | 6.50 | 6.835 | 2.001M |
| Oct 31, 2024 | 5.88 | 7.37 | 5.87 | 6.62 | 5.851M |
| Oct 30, 2024 | 5.66 | 5.849 | 5.621 | 5.71 | 313475.0 |
| Oct 29, 2024 | 5.74 | 5.83 | 5.64 | 5.715 | 504813.0 |
| Oct 28, 2024 | 5.29 | 5.79 | 5.29 | 5.78 | 699838.0 |
| Oct 25, 2024 | 5.38 | 5.57 | 5.22 | 5.24 | 615077.0 |
| Oct 24, 2024 | 5.40 | 5.46 | 5.30 | 5.33 | 443363.0 |
| Oct 23, 2024 | 5.59 | 5.701 | 5.31 | 5.39 | 701584.0 |
| Oct 22, 2024 | 5.40 | 5.68 | 5.285 | 5.64 | 645429.0 |
| Oct 21, 2024 | 5.63 | 5.77 | 5.395 | 5.45 | 758617.0 |
| Oct 18, 2024 | 5.52 | 5.70 | 5.46 | 5.65 | 440193.0 |
| Oct 17, 2024 | 5.65 | 5.65 | 5.43 | 5.505 | 382584.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.31
Minimum
Nov 22 2019
28.86
Maximum
Jun 28 2021
8.914
Average
8.08
Median
Dec 08 2022
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.7026 |
| Palatin Technologies Inc | 0.9142 |
| iBio Inc | 2.27 |
| Theriva Biologics Inc | 1.26 |
| Oragenics Inc | 0.2822 |
Price Related Metrics
| Price to Book Value | 5.838 |
| Earnings Yield | -5.71% |
| Market Cap | 757.65M |